|Last Price$0.05||Day Change (%)37.43%|
|Open Price$0.05||Day Change ($)0.01|
|Day Range0.05–0.05||52-Week Range0.04–0.09|
As of Tue 7/26/2016 10:49:00 AM | USD
Global Artificial Tears Market Report 2016-2021 - Analysis, Technologies & Forecasts - Vendors: Allergan, Akorn, Alcon - Research and Markets
Global Age-related Macular Degeneration Market Growth of 7.37% CAGR by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Vendors: Bayer Healthcare, Novartis, Alcon - Research and Markets
PanOptica Reports Positive Results from Phase 1/2 Clinical Trial of PAN-90806, a Novel Topical Anti-VEGF Eye Drop
The stocks mentioned in this article be holdings in the managed portfolios of Validea Capital Management, a separate asset management firm founded by Validea.com founder John Reese. Validea Capital Management, which an SEC registered investment advisory firm and a separate company from Validea.com, ...
Alcon benefits from leadership positions across eye care.
Four offerings deemed to be right for right now.
The company's diverse operating divisions and robust pipeline should lead to steady growth.
BBH Core Select manager Tim Hartch says focusing on easy-to-understand businesses, particularly in the financials and consumer defensive sectors, helps his team avoid negative surprises.